Dysregulation of energy metabolism in Alzheimer's disease

被引:0
|
作者
Yue Yuan [1 ]
Gang Zhao [2 ]
Yang Zhao [1 ]
机构
[1] The First Hospital of Jilin University,Department of Neurology
[2] China Resources Pharmaceutical Commercial Group,undefined
关键词
Alzheimer’s disease; Glucose metabolism; Glucose transporters; O-GlcNAc; Mitochondrial dysfunction; Mitochondrial autophagy; Mitochondrial genetics; β-Amyloid; Tau protein;
D O I
10.1007/s00415-024-12800-8
中图分类号
学科分类号
摘要
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Its etiology and associated mechanisms are still unclear, which largely hinders the development of AD treatment strategies. Many studies have shown that dysregulation of energy metabolism in the brain of AD is closely related to disease development. Dysregulation of brain energy metabolism in AD brain is associated with reduced glucose uptake and utilization, altered insulin signaling pathways, and mitochondrial dysfunction. In this study, we summarized the relevant pathways and mechanisms regarding the dysregulation of energy metabolism in AD. In addition, we highlight the possible role of mitochondrial dysfunction as a central role in the AD process. A deeper understanding of the relationship between energy metabolism dysregulation and AD may provide new insights for understanding learning memory impairment in AD patients and in improving AD prevention and treatment.
引用
收藏
相关论文
共 50 条
  • [41] Epigenetic dysregulation in Alzheimer's disease peripheral immunity
    Ramakrishnan, Abhirami
    Piehl, Natalie
    Simonton, Brooke
    Parikh, Milan
    Zhang, Ziyang
    Teregulova, Victoria
    van Olst, Lynn
    Gate, David
    NEURON, 2024, 112 (08) : 1235 - 1248.e5
  • [42] Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
    Magi, Simona
    Castaldo, Pasqualina
    Macri, Maria Loredana
    Maiolino, Marta
    Matteucci, Alessandra
    Bastioli, Guendalina
    Gratteri, Santo
    Amoroso, Salvatore
    Lariccia, Vincenzo
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [43] Circadian dysregulation and Alzheimer's disease: A comprehensive review
    Peter Iacobelli
    Brain Science Advances, 2022, 8 (04) : 221 - 257
  • [44] An Alzheimer's disease hypothesis based on transcriptional dysregulation
    Robakis, NK
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (02): : 80 - 85
  • [45] NMDA and AMPA receptors dysregulation in Alzheimer's disease
    Babaei, Parvin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 908
  • [46] Epigenetic dysregulation in Alzheimer's disease: cause or consequence?
    van den Hove, Daniel L. A.
    Kenis, Gunter
    Rutten, Bart P. F.
    EPIGENOMICS, 2014, 6 (01) : 9 - 11
  • [47] Robust Gene Dysregulation in Alzheimer's Disease Brains
    Feng, Xuemei
    Bai, Zhouxian
    Wang, Jiajia
    Xie, Bin
    Sun, Jiya
    Han, Guangchun
    Song, Fuhai
    Crack, Peter J.
    Duan, Yong
    Lei, Hongxing
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (02) : 587 - 597
  • [48] Modeling the calcium dysregulation hypothesis of Alzheimer's disease
    Monteiro, Julio
    Netto, Marcio Lobo
    Andina, Diego
    Pelaez, Javier Ropero
    CIMMACS '07: PROCEEDINGS OF THE 6TH WSEAS INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE, MAN-MACHINE SYSTEMS AND CYBERNETICS, 2007, : 53 - +
  • [49] The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease
    Nagy, Zsuzsanna
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (04): : 402 - 408
  • [50] Dysregulation of BDNF in Prefrontal Cortex in Alzheimer's Disease
    Aarons, Toby
    Bradburn, Steven
    Robinson, Andrew
    Payton, Antony
    Pendleton, Neil
    Murgatroyd, Chris
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (04) : 1089 - 1097